GlassScriptPhysician profile
Chitto P Sarkar
NPI 1477529360
$2,377.90
in general payments reported to CMS, 2019-2025
10 companies · $35.60 in 2025
The $35.60 reported for 2025 was less than what a typical Neuromusculoskeletal Medicine & Omm provider received nationally (typical 2025 total: $119).
See the full distribution for Neuromusculoskeletal Medicine & OMM
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $542 · 2020: $303 · 2021: $506 · 2022: $517 · 2023: $119 · 2024: $355 · 2025: $35.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $616.94 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $614.08 | 2019-2022 | |
| Novo Nordisk INC | $492.25 | 2019-2022 | |
| Boston Scientific Corporation | $145.90 | 2022 | |
| Lilly USA, LLC | $124.60 | 2022 | |
| Janssen Pharmaceuticals, INC | $118.32 | 2019 | |
| Treace Medical Concepts, INC. | $118.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $114.60 | 2022 | |
| Corcept Therapeutics | $21.77 | 2025 | Korlym |
| Stimwave Technologies Incorporated | $11.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chitto Sarkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.